Meningococcal disease is a severe, fast-progressing infection; vaccination is key for high-risk groups, preventing ...

was approved by the US FDA to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135 in people aged 11–55 years. The first meningococcal vaccine ...